{"id":"CHEMBL1088762","canonicalSmiles":"COc1ccc(S(=O)(=O)N2CCN(S(=O)(=O)c3ccc4c(c3)OCCO4)CC2)cc1","inchiKey":"HMGDKYUJSFVHIY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1088762","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["26668724","57646205","57646206","847943"],"drugbank":["DB07697"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1095284","canonicalSmiles":"N[C@@H](C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(CSc3c[nH]nn3)CS[C@H]12)c1ccc(O)cc1","inchiKey":"UOCJDOLVGGIYIQ-PBFPGSCMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CEFATRIZINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BL-S640","Cefatrizine","Cefatrizine propylene glycolate","J01DB07","S-640P"],"crossReferences":{"PubChem":["124896641","144206927"],"Wikipedia":["Cefatrizine"],"drugbank":["DB13266"]},"childChemblIds":["CHEMBL3115472"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1160571","canonicalSmiles":"O=P(O)(O)OP(=O)(O)O","inchiKey":"XPPKVPWEQAFLFU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PYROPHOSPHORIC ACID","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["4253134"],"Wikipedia":["Pyrophosphoric_acid"],"drugbank":["DB04160"],"chEBI":["29888"]},"childChemblIds":["CHEMBL3184949","CHEMBL450079","CHEMBL2028376"],"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL1181731","canonicalSmiles":"COCCOCCOCCOCCOC(=O)OC[n+]1ccc(N/C(=N/CCCCCCOc2ccc(Cl)cc2)NC#N)cc1","inchiKey":"RXXJCNMVVRGOJB-UHFFFAOYSA-O","drugType":"Small molecule","blackBoxWarning":false,"name":"TEGLARINAD","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Teglarinad cation","Teglarinad ion"],"childChemblIds":["CHEMBL190412"],"linkedTargets":{"rows":["ENSG00000105835"],"count":1},"linkedDiseases":{"rows":["EFO_0000574"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1190","canonicalSmiles":"C[N+](C)(C)CCCCCCCCCC[N+](C)(C)C","inchiKey":"MTCUAOILFDZKCO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DECAMETHONIUM","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Decamethonium","Decamethonium cation","Decamethonium ion","Syncurine"],"crossReferences":{"PubChem":["11111046","11111047","26756594","90341654"],"drugbank":["DB01245"],"chEBI":["41934"]},"childChemblIds":["CHEMBL1134"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982."}
{"id":"CHEMBL119423","canonicalSmiles":"Sc1[nH]cnc2nncc1-2","inchiKey":"PYAOPMWCFSVFOT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TISOPURINE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Exuracid"],"synonyms":["NSC-1392","Tisopurine"],"crossReferences":{"drugbank":["DB13807"]},"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for gout."}
{"id":"CHEMBL1199480","canonicalSmiles":"CCCCCCCCN=c1ccn(CCCCCCCCCCn2ccc(=NCCCCCCCC)cc2)cc1","inchiKey":"ZVXNYZWXUADSRV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OCTENIDINE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Octenidine"],"crossReferences":{"drugbank":["DB12624"]},"childChemblIds":["CHEMBL36342","CHEMBL2105832"],"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL1200374","canonicalSmiles":"C=C1C[C@@H]2[C@H](CC[C@]3(C)C(=O)CC[C@@H]23)[C@@]2(C)C=CC(=O)C=C12","inchiKey":"BFYIZQONLCFLEV-DAELLWKTSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"EXEMESTANE","yearOfFirstApproval":1999,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Aromasin","Exemestane"],"synonyms":["Exemestane","FCE-24304","FCE24304","NSC-758907","PNU-155971"],"crossReferences":{"DailyMed":["exemestane"],"PubChem":["144205052","170464628","26719821","49681613"],"Wikipedia":["Exemestane"],"drugbank":["DB00990"],"chEBI":["4953"]},"linkedTargets":{"rows":["ENSG00000137869"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","EFO_0003869","MONDO_0004658","EFO_1000098","MONDO_0008170","MONDO_0007254","EFO_1000235","EFO_0000305","MONDO_0008315","EFO_0003060","EFO_0000311","EFO_0000304","EFO_0006861","MONDO_0011962","EFO_0000574","EFO_0000432","MONDO_0024880","EFO_1000233"],"count":18},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1999 and has 5 approved and 8 investigational indications."}
{"id":"CHEMBL1200561","canonicalSmiles":"COc1cc2nc(N3CCN(C(=O)C4COc5ccccc5O4)CC3)nc(N)c2cc1OC.CS(=O)(=O)O","inchiKey":"VJECBOKJABCYMF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DOXAZOSIN MESYLATE","yearOfFirstApproval":1990,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL707","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cardozin xl","Cardura","Cardura xl","Cascor","Colixil xl","Doxadura","Doxazosin mesylate","Doxzogen xl","Larbex xl","Oxandosin xl","Raporsin xl","Slocinx xl"],"synonyms":["Alfadil","Doxazosin (as mesilate)","Doxazosin mesilate","Doxazosin mesylate","Doxazosin methanesulfonate","NSC-759284","UK-33,274-27","UK-33274-27"],"crossReferences":{"DailyMed":["doxazosin%20mesylate"],"PubChem":["144204347","170465395","50106256","56422468","85231302","855527"],"chEBI":["4709"]},"linkedTargets":{"rows":["ENSG00000171873","ENSG00000170214","ENSG00000120907"],"count":3},"linkedDiseases":{"rows":["EFO_0000284","EFO_0000612","EFO_0009094","EFO_0000537"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1990 and has 3 approved indications."}
{"id":"CHEMBL1200836","canonicalSmiles":"Clc1ccc(CO/N=C(\\Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1.O=[N+]([O-])O","inchiKey":"WVNOAGNOIPTWPT-NDUABGMUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OXICONAZOLE NITRATE","yearOfFirstApproval":1988,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1262","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Oceral","Oxiconazole nitrate","Oxistat"],"synonyms":["NSC-758958","Oxiconazole nitrate","RO 13-8996","RO-13-8996","SGD 301-76","SGD-301-76","ST-813"],"crossReferences":{"DailyMed":["oxiconazole%20nitrate"],"PubChem":["144205020","170465226","26749046"],"chEBI":["7826"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1988 and is indicated for tinea and tinea pedis."}
{"id":"CHEMBL1207949","canonicalSmiles":"O=P(O)(O)[C@@H](CCCc1cccc(Oc2ccccc2)c1)S(=O)(=O)O","inchiKey":"RCGCZPXSRLLKCK-MRXNPFEDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1207949","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07420"]},"childChemblIds":["CHEMBL462651"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1213583","canonicalSmiles":"C#C[C@]1(O)C=C[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3CC[C@@]21CC","inchiKey":"SIGSPDASOTUPFS-XUDSTZEESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GESTODENE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Gestodene","SH B 331","SH-B-331"],"crossReferences":{"PubChem":["144205785","170466131"],"Wikipedia":["Gestodene"],"drugbank":["DB06730"]},"linkedTargets":{"rows":["ENSG00000082175"],"count":1},"linkedDiseases":{"rows":["EFO_0001065"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of III."}
{"id":"CHEMBL1230193","canonicalSmiles":"C[C@H]1O[C@H](O[C@@H]2[C@@H](CO)O[C@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@@H](O)[C@@H]1N[C@H]1C=C(CO)[C@@H](O)[C@H](O)[C@H]1O","inchiKey":"SNMISNLUIRCRQE-SFSRYZOZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1230193","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02889"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1231234","canonicalSmiles":"C[C@H](NC(=O)OCc1ccccc1)C(=O)O","inchiKey":"TYRGLVWXHJRKMT-QMMMGPOBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1231234","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04634"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1232392","canonicalSmiles":"O[C@H](CS)[C@H](O)CS","inchiKey":"VHJLVAABSRFDPM-QWWZWVQMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1232392","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02184"],"chEBI":["42170"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1235541","canonicalSmiles":"Sc1ccccn1","inchiKey":"WHMDPDGBKYUEMW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"2-MERCAPTOPYRIDINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["2-Mercaptopyridine"],"crossReferences":{"Wikipedia":["2-Mercaptopyridine"],"drugbank":["DB03329"],"chEBI":["45223"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1235825","canonicalSmiles":"CN(CC[C@H](N)C(=O)O)C[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O","inchiKey":"JISVTSUBJCPLSV-TWBCTODHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"aza-AdoMet","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["aza-AdoMet"],"crossReferences":{"drugbank":["DB03458"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1239","canonicalSmiles":"O=C(OCc1ccccc1)c1ccccc1","inchiKey":"SESFRYSPDFLNCH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BENZYL BENZOATE","yearOfFirstApproval":1976,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ascabiol","Benzyl benzoate","Mange Treatment","Scabanca","Vanzoate"],"synonyms":["Benzoic acid, benzyl ester","Benzyl Benzoate","Benzyl benzoate","Benzylis benzoas","FEMA NO. 2138","NSC-8081","Scabiozon","Venzonate"],"crossReferences":{"PubChem":["144204925","144208535","144213729","170465382","26748657","26753738","47193672"],"Wikipedia":["Benzyl_benzoate"],"drugbank":["DB00676"],"chEBI":["41237"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1976 and is indicated for parasitic infection."}
{"id":"CHEMBL131854","canonicalSmiles":"O=C([C@@H](O)CO)N1CC=C(c2c(F)cc(N3C[C@H](COc4ccon4)OC3=O)cc2F)CC1","inchiKey":"HBUJYEUPIIJJOS-PBHICJAKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"POSIZOLID","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AZD-2563","AZD-5847","AZD2563","Posizolid"],"crossReferences":{"drugbank":["DB04850"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1329455","canonicalSmiles":"CCOC(=O)[N-]c1c[n+](N2CCOCC2)no1","inchiKey":"XLFWDASMENKTKL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MOLSIDOMINE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Corvasal","Corvaton","Corvaton mite","Corvaton ret"],"synonyms":["CAS 276","CAS-276","Molsidomine","Morsydomine","NSC-757398"],"crossReferences":{"PubChem":["11111444","144203743","170465872","50104240","56423118","56463055","85231130","856013","90341588"],"drugbank":["DB09282"]},"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for cardiovascular disease."}
{"id":"CHEMBL1435","canonicalSmiles":"Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1","inchiKey":"MLYYVTUWGNIJIB-BXKDBHETSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CEFAZOLIN","yearOfFirstApproval":1973,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Cefazolin","Cephazolin","J01DB04","SK&F-41558"],"crossReferences":{"PubChem":["144205244","170465254","29215418","47193754","90340701"],"Wikipedia":["Cefazolin"],"drugbank":["DB01327"],"chEBI":["474053"]},"childChemblIds":["CHEMBL1200523"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1973 and has 5 approved and 16 investigational indications."}
{"id":"CHEMBL1525287","canonicalSmiles":"COP(=S)(OC)Oc1ccc(S(=O)(=O)N(C)C)cc1","inchiKey":"JISACBWYRJHSMG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1525287","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144205499","144212224","170466840","29216324"],"drugbank":["DB11408"],"chEBI":["38677"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1577","canonicalSmiles":"CN1C(CCl)Nc2cc(Cl)c(S(N)(=O)=O)cc2S1(=O)=O","inchiKey":"CESYKOGBSMNBPD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"METHYCLOTHIAZIDE","yearOfFirstApproval":1960,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Aquatensen","Enduron","Methyclothiazide"],"synonyms":["Methyclothiazide","NSC-110431"],"crossReferences":{"PubChem":["144206003","170465243","92764517"],"Wikipedia":["Methyclothiazide"],"drugbank":["DB00232"],"chEBI":["6847"]},"linkedTargets":{"rows":["ENSG00000070915"],"count":1},"linkedDiseases":{"rows":["EFO_0000319"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1960 and is indicated for cardiovascular disease."}
{"id":"CHEMBL1697","canonicalSmiles":"COc1ccc([C@@H]2Sc3ccccc3N(CCN(C)C)C(=O)[C@@H]2OC(C)=O)cc1.Cl","inchiKey":"HDRXZJPWHTXQRI-BHDTVMLSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DILTIAZEM HYDROCHLORIDE","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL23","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Adizem-60","Adizem-sr","Adizem-xl","Angiozem 60","Angiozem cr 120","Angiozem cr 90","Angitil sr 120","Angitil sr 180","Angitil sr 90","Angitil xl 240","Angitil xl 300","Anoheal","Bi-carzem sr","Bi-carzem xl","Britiazim","Calazem","Calcicard","Calcicard cr","Cardizem","Cardizem cd","Cardizem la","Cardizem sr","Cartia xt","Dilacor","Dilacor xr","Dilcardia sr","Dilcardia xl","Dilt-cd","Diltiazem hydrochloride","Diltzac","Dilzem sr 120","Dilzem sr 60","Dilzem sr 90","Dilzem xl 120","Dilzem xl 180","Dilzem xl 240","Disogram sr","Horizem sr 120","Horizem sr 60","Horizem sr 90","Kentiazem","Kenzem sr","Optil","Optil sr 120","Optil sr 180","Optil sr 90","Optil xl 240","Optil xl 300","Retalzem 60","Slozem","Slozem 120","Slozem 180","Slozem 240","Taztia xt","Tiamex","Tiazac","Tildiem","Tildiem la 200","Tildiem la 300","Tildiem ret 120","Tildiem ret 90","Uard 120xl","Uard 180xl","Uard 240xl","Uard 300xl","Viazem xl","Zemret 180 xl","Zemret 240 xl","Zemret 300 xl","Zemtard 120 xl","Zemtard 180 xl","Zemtard 240 xl","Zemtard 300 xl","Zildil sr"],"synonyms":["Adizem","Altiazem","CRD-401","Cartia","Deltazen","Diladel","Dilpral","Dilrene","Diltiazem hcl","Diltiazem hydrochloride","Dilzem","Dilzene","Masdil","NSC-759576","RG 83606","RG-83606","Taztia","Zilden"],"crossReferences":{"DailyMed":["diltiazem%20hydrochloride"],"PubChem":["50106088","56422509","855699"],"chEBI":["645509"]},"linkedTargets":{"rows":["ENSG00000157388","ENSG00000081248","ENSG00000151067","ENSG00000102001"],"count":4},"linkedDiseases":{"rows":["EFO_0003913","HP_0012390","EFO_0000275","EFO_0003144","EFO_0000764","EFO_0000701","EFO_0004225","HP_0002019","EFO_0000537","EFO_1001951"],"count":10},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1982 and has 4 approved and 6 investigational indications."}
{"id":"CHEMBL171281","canonicalSmiles":"N[C@H](CS)C(=O)O","inchiKey":"XUJNEKJLAYXESH-UWTATZPHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL171281","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["26756687"],"drugbank":["DB03201"],"chEBI":["16375"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1743046","drugType":"Antibody","blackBoxWarning":false,"name":"NARNATUMAB","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["IMC RON-8","IMC-RON-8","IMC-RON8","Narnatumab","RON-8","RON8"],"linkedTargets":{"rows":["ENSG00000164078"],"count":1},"linkedDiseases":{"rows":["EFO_0000311"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1743056","drugType":"Antibody","blackBoxWarning":false,"name":"PATECLIZUMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MLTA-3698A","MLTA3698A","PRO-283698","PRO283698","Pateclizumab","RG-7416","RG7415"],"linkedTargets":{"rows":["ENSG00000226979"],"count":1},"linkedDiseases":{"rows":["EFO_0000685"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL1796998","canonicalSmiles":"FS(F)(F)(F)(F)F","inchiKey":"SFZCNBIFKDRMGX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SULFUR HEXAFLUORIDE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Sonovue (for the microbubble formulation)"],"synonyms":["BRI","Sulfur hexafluoride","Sulfur hexafluoride, phospholipid microspheres"],"crossReferences":{"drugbank":["DB11104"],"chEBI":["30496"]},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL1808698","canonicalSmiles":"O=C[C@H]([18F])[C@@H](O)[C@H](O)[C@H](O)CO","inchiKey":"AOYNUTHNTBLRMT-MXWOLSILSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1808698","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1908940","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB09502"],"chEBI":["49136"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL190677","canonicalSmiles":"O=C(c1ccccc1)C(O)c1ccccc1","inchiKey":"ISAOCJYIOMOJEB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BENZOIN","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Benzoin","Benzoin resin","Benzoin resin, unspecified","Benzoin tincture","Benzoin usp","FEMA NO. 2132","Gum benzoin","Gum benzoin tincture","NSC-8082"],"crossReferences":{"PubChem":["144204677","144209086","144213107","170465507","17390021","26752995","56463440"],"Wikipedia":["Benzoin"],"drugbank":["DB14020"],"chEBI":["17682"]},"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL1908845","canonicalSmiles":"CO[C@H]1O[C@H](COS(=O)(=O)O)[C@@H](O[C@H]2O[C@@H](C(=O)O)[C@@H](O[C@H]3O[C@H](COS(=O)(=O)O)[C@@H](O[C@@H]4O[C@H](C(=O)O)[C@@H](O[C@H]5O[C@H](COS(=O)(=O)O)[C@@H](OC)[C@H](OC)[C@H]5OC)[C@H](OC)[C@H]4OC)[C@H](OS(=O)(=O)O)[C@H]3OS(=O)(=O)O)[C@H](OC)[C@H]2OC)[C@H](OS(=O)(=O)O)[C@H]1OS(=O)(=O)O","inchiKey":"AJBMORBNKXNZSF-SXFYKSCTSA-N","drugType":"Oligosaccharide","blackBoxWarning":false,"name":"IDRAPARINUX","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["SR 34006","SR-34006"],"childChemblIds":["CHEMBL1908371"],"linkedTargets":{"rows":["ENSG00000126218"],"count":1},"linkedDiseases":{"rows":["EFO_0000275","EFO_0003827","EFO_0003907"],"count":3},"description":"Oligosaccharide drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL191958","canonicalSmiles":"CNCCn1c(=O)c2cc(OC)c(OC)cc2c2cnc3cc4c(cc3c21)OCO4","inchiKey":"BAORCAMWLWRZQG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GENZ-644282","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Genz-644282"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL194322","canonicalSmiles":"CC(C)c1nnc2ccc(-c3ocnc3-c3ccc(F)cc3)cn12","inchiKey":"OVCXRBARSPBVMC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CP-808844","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CP-808844"],"crossReferences":{"drugbank":["DB04797"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL202431","canonicalSmiles":"O=C(Nc1c(F)cc(-c2cccc(OC(F)(F)F)c2)cc1F)c1ccsc1C(=O)O","inchiKey":"CGNHUSCKOHDSMR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL202431","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07977"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2096641","drugType":"Small molecule","blackBoxWarning":false,"name":"SODIUM PERTECHNETATE TC 99M","maximumClinicalTrialPhase":4,"parentId":"CHEMBL2110571","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Minitec","Pertscan-99m","Radiogenix system","Sodium pertechnetate tc 99m","Tc 99m generator","Technelite","Technetium tc 99m generator","Ultra-technekow fm"],"synonyms":["Pertechnetate (99mtc) sodium","Pertechnetate sodium tc-99m","Sodium pertechnetate (99m tc)","Sodium pertechnetate (99mtc) injection","Sodium pertechnetate (na99mtco4)","Sodium pertechnetate (tc 99m)","Sodium pertechnetate tc 99m","Sodium pertechnetate tc-99m","Sodium pertechnetium (99mtc) injection","Technetium (99Mtc) Pertechnetate","Technetium (99mtc) pertechnetate","Technetium tc-99m sodium pertechnetate","Technetium tc-99m sodium pertechnetate generator"],"crossReferences":{"DailyMed":["technetium%20tc-99m%20sodium%20pertechnetate%20generator"]},"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL2103745","canonicalSmiles":"N#C[C@@H]1C[C@@H]2C[C@@H]2N1C(=O)[C@@H](N)C12CC3CC(CC(O)(C3)C1)C2.O","inchiKey":"AFNTWHMDBNQQPX-NHKADLRUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SAXAGLIPTIN","maximumClinicalTrialPhase":4,"parentId":"CHEMBL385517","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Onglyza"],"synonyms":["BMS-477118","BMS-477118-11","NSC-760407","Saxagliptin","Saxagliptin hydrate","Saxagliptin monohydrate"],"crossReferences":{"chEBI":["71271"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for diabetes mellitus and has 5 investigational indications."}
{"id":"CHEMBL2104255","canonicalSmiles":"CCCCCCCCCCCC[N+](CCO)(CCO)Cc1ccccc1.[Cl-]","inchiKey":"UUSQFLGKGQEVCM-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"BENZOXONIUM CHLORIDE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL2110609","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Absonal","Bactofen","Beloran","Benzoxonium chloride","Bialcol","Bradophen","Cohortan","D-301","Katanol c12","Lomades","NSC-141905","Orofar","ZY-15021"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2104926","canonicalSmiles":"N#CCCN1C(=O)C(O)N=C(c2ccccc2F)c2cc(Cl)ccc21","inchiKey":"XAXMYHMKTCNRRZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CINOLAZEPAM","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cinolazepam","Gerodorm"],"crossReferences":{"drugbank":["DB01594"],"chEBI":["59514"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2105689","canonicalSmiles":"N#C/C(=C1/SC[C@@H](c2ccc(Cl)cc2Cl)S1)n1ccnc1","inchiKey":"YTAOBBFIOAEMLL-REQDGWNSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LULICONAZOLE","yearOfFirstApproval":2013,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Luzu"],"synonyms":["Lulicon","Luliconazole","NND-502","PR-2699"],"crossReferences":{"DailyMed":["luliconazole"],"PubChem":["144206495","144206527","144206804"],"drugbank":["DB08933"],"chEBI":["34825"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2013 and is indicated for tinea pedis and tinea."}
{"id":"CHEMBL2106988","canonicalSmiles":"CC(=O)OCOC(=O)[C@@H]1N2C(=O)[C@@H](NC(=O)Cc3ccccc3)[C@H]2SC1(C)C","inchiKey":"NLOOMWLTUVBWAW-HLLBOEOZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PENAMECILLIN","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Havapen"],"synonyms":["Penamecillin","WY-20,788","WY-20788"],"crossReferences":{"drugbank":["DB13739"]},"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for bacterial disease."}
{"id":"CHEMBL2107067","canonicalSmiles":"CCCCCCCCCCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C","inchiKey":"UDSFVOAUHKGBEK-CNQKSJKFSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"TESTOSTERONE UNDECANOATE","yearOfFirstApproval":2014,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Andriol","Aveed","Jatenzo","Nebido","Restandol","Restandol testocap","Undestor"],"synonyms":["MK-3033","ORG 538","ORG-538","TSX-011","Testosterone 17.beta.-undecylate","Testosterone undecanoate","Testosterone undecylate"],"crossReferences":{"DailyMed":["testosterone%20undecanoate"],"drugbank":["DB13946"]},"linkedTargets":{"rows":["ENSG00000169083"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","EFO_0009686","EFO_0008572","EFO_0004234","EFO_0001645","EFO_0000681","EFO_1001919","EFO_1001006","EFO_0003929","MONDO_0008315","MONDO_0018555","EFO_0003913","EFO_1001078","GO_0007568","MONDO_0002146","EFO_0004714","HP_0003549","EFO_0003144"],"count":18},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2014 and has 5 approved and 7 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL2107872","drugType":"Protein","blackBoxWarning":false,"name":"DELCASERTIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BMS-875944","Delcasertib","KAI-9803","Kai-9803"],"linkedTargets":{"rows":["ENSG00000163932"],"count":1},"linkedDiseases":{"rows":["EFO_0000612"],"count":1},"description":"Protein drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2107914","drugType":"Unknown","blackBoxWarning":false,"name":"OPIUM","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["IDS-NO-001","Opium","Opium tincture","Papaver somniferum resin"],"description":"Unknown drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL2108172","drugType":"Unknown","blackBoxWarning":false,"name":"ACACIA","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Acacia","Acacia arabica","Acacia circummarginata resin","Acacia cufodontii resin","Acacia mucilage","Acacia oxyosprion resin","Acacia powder","Acacia rupestris resin","Acacia senegal","Acacia senegal gum","Acacia senegal resin","Acacia seyal","Acacia spinosa resin","Acacia verek resin","Acacia volkii resin","Acacia, spray-dried","E-414-","FEMA NO. 2001","Gum acacia","Gum arabic","Gum arabic (acacia senegal)","Gum arabic (acacia seyal)","Gum senegal","Gummi arabicum","INS NO.414","INS-414","Kher resin","Mimosa senegal resin","Rfaudraksha resin","Senegalia senegal resin","Thorny acacia resin"],"description":"Unknown drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL2108407","drugType":"Antibody","blackBoxWarning":false,"name":"FARALIMOMAB","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Faralimomab"],"description":"Antibody drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2109464","drugType":"Antibody","blackBoxWarning":false,"name":"CNTO-5825","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CNTO-5825","Cnto-5825"],"description":"Antibody drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2109506","drugType":"Antibody","blackBoxWarning":false,"name":"HU3S193","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["HU3S193","Hu3s193"],"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 6 investigational indications."}
{"id":"CHEMBL2109680","drugType":"Antibody","blackBoxWarning":false,"name":"IDEC-159 90Y","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["IDEC-159","Idec-159 (90y)","Idec-159 90y"],"description":"Antibody drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2135887","canonicalSmiles":"CC=Cc1ccc(O)c(OC)c1","inchiKey":"BJIOGJUNALELMI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CIS/TRANS-ISOEUGENOL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144204689","144209631","144210623","170465654"],"drugbank":["DB14188"],"chEBI":["18224"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2207138","canonicalSmiles":"CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCSC)NC(=O)[C@@H]1CSSC[C@H](N)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)C(=O)NCC(=O)N[C@H](C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)O)C(C)C","inchiKey":"CWCXERYKLSEGEZ-KDKHKZEGSA-N","drugType":"Protein","blackBoxWarning":false,"name":"PROCALCITONIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Calcitonin, pro","Procalcitonin","Procalcitonin human"],"description":"Protein drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL2364617","canonicalSmiles":"CC(=O)O.CC(C)(N)C(=O)N[C@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](Cc1c[nH]c2ccccc12)NC=O","inchiKey":"WVDSKQXKCDZXLH-OHIDFYLOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MACIMORELIN ACETATE","yearOfFirstApproval":2017,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL278623","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Macrilen"],"synonyms":["ARD 07","D-87575","EP 1572","Macimorelin acetate"],"crossReferences":{"DailyMed":["macimorelin%20acetate"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2017."}
{"id":"CHEMBL24722","canonicalSmiles":"CCCCCCCCCCCCO","inchiKey":"LQZZUXJYWNFBMV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DODECANOL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["1-Dodecanol","Dodecan-1-ol"],"crossReferences":{"PubChem":["144209322","144210440"],"Wikipedia":["Dodecanol"],"drugbank":["DB06894"],"chEBI":["28878"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL24811","canonicalSmiles":"O=Cc1ccccc1OP(=O)(O)OCC1CCCCC1","inchiKey":"YBEVTZVQKMYQPM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"Phosphoric Acid Cyclohexylmethyl Ester 2-Formyl-Phenyl Ester","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Phosphoric Acid Cyclohexylmethyl Ester 2-Formyl-Phenyl Ester"],"crossReferences":{"drugbank":["DB03114"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL249847","canonicalSmiles":"CNC(=O)[C@H](Cc1ccccc1)NC(=O)Nc1n[nH]c(=S)s1","inchiKey":"RKWXKADYTDWZIJ-VIFPVBQESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PNU-107859","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["PNU-107859"],"crossReferences":{"drugbank":["DB07390"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL279597","canonicalSmiles":"C[C@H](N)C(=O)O","inchiKey":"QNAYBMKLOCPYGJ-REOHCLBHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"L-ALANINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["11113404"],"drugbank":["DB00160"],"chEBI":["16977"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL29641","canonicalSmiles":"COc1cc2ncnc(Nc3cccc(SC)c3)c2cc1OC","inchiKey":"FUSDVOSGGMBSMK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL29641","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02984"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL300982","canonicalSmiles":"CC1(C)Cc2c(-c3ccccc3)c(-c3ccc(Cl)cc3)c(CC(=O)O)n2C1","inchiKey":"UAWXGRJVZSAUSZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LICOFELONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Licofelone","ML-3000","Ml 3000"],"crossReferences":{"PubChem":["137275875"],"drugbank":["DB04725"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3039530","canonicalSmiles":"O=c1ccc2c([C@@H](O)CNCCCCCCOCC(F)(F)c3ccccc3)ccc(O)c2[nH]1","inchiKey":"SFYAXIFVXBKRPK-QFIPXVFZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ABEDITEROL","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Abediterol","LAS-100977","LAS100977"],"crossReferences":{"drugbank":["DB12100"]},"childChemblIds":["CHEMBL3039510"],"linkedTargets":{"rows":["ENSG00000169252"],"count":1},"linkedDiseases":{"rows":["MONDO_0004979","EFO_0000341"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL3120793","canonicalSmiles":"CC(C)OC(=O)[C@H](C)N[P@](=O)(OC[C@H]1O[C@@](C#N)(c2ccc3c(N)ncnn23)[C@](C)(O)[C@@H]1OC(=O)C(C)C)Oc1ccccc1","inchiKey":"YAAQYJCOIFNMKX-RSTNYOGXSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GS-6620","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GS-6620","Gs-6620"],"crossReferences":{"drugbank":["DB15222"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL313136","canonicalSmiles":"CC1CC(=O)NN=C1c1ccc(NN=C(C#N)C#N)cc1","inchiKey":"WHXMKTBCFHIYNQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SIMENDAN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Simendan"],"crossReferences":{"Wikipedia":["Levosimendan"],"drugbank":["DB12286"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3137355","drugType":"Small molecule","blackBoxWarning":false,"name":"VEPOLOXAMER","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Kolliphor p 188","Kolliphor p188","Lutrol f 68","Lutrol f68","MST-188","Pluracare f 68","Pluronic f-68","Pluronic f68","Pluronic f68lf","Poloxalkol","Poloxamer 188","Poloxamer 188lf","Poloxamer-188","Polykol","Vepoloxamer"],"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL3182444","canonicalSmiles":"O=C(O)C1(Cc2cccc(Nc3nccs3)n2)CCC(Oc2cccc(Cl)c2F)CC1","inchiKey":"LCVIRAZGMYMNNT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MK-5108","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MK 5108","MK5108","Mk-5108","VX-689"],"crossReferences":{"PubChem":["174006374"]},"linkedTargets":{"rows":["ENSG00000087586"],"count":1},"linkedDiseases":{"rows":["EFO_0000616"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL324942","canonicalSmiles":"O=C(Nc1cc(C2CC2)n[nH]1)c1ccccc1","inchiKey":"LUCORKWTQSQFFU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL324942","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02647"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL334533","canonicalSmiles":"CCCCCCC(C)(C)c1cc(O)c2c(c1)OC(C)(C)[C@H]1CC=C(CO)C[C@H]21","inchiKey":"SSQJFGMEZBFMNV-PMACEKPBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DEXANABINOL","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["11-oh-thc","Dexanabinol","HU-210","HU-211","PA-50211","PRS-211007","PRS-211007-000","Sinnabidol"],"crossReferences":{"drugbank":["DB06444"]},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL335954","canonicalSmiles":"O=C(N[C@@H](Cc1ccccc1)C(=O)N1CC(C(=O)O)C1)c1cc2cc(Cl)ccc2[nH]1","inchiKey":"RONLONYAIBUEKT-IBGZPJMESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CP-403700","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CP-403700"],"crossReferences":{"drugbank":["DB03744"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3545081","drugType":"Small molecule","blackBoxWarning":false,"name":"RG-7304","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CH-5126766","CH5126766","CKI-27","R-7304","Rg-7304","Ro 5126766","Ro-5126766"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3545253","canonicalSmiles":"[18F]c1ccc(-c2ccc3c(c2)[nH]c2ccncc23)cn1","inchiKey":"GETAAWDSFUCLBS-SJPDSGJFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FLORTAUCIPIR F 18","yearOfFirstApproval":2020,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL3546271","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Tauvid"],"synonyms":["(F-18)T807","18F-AV-1451","AV-1451 F-18","Flortaucipir (18f)","Flortaucipir f 18","Flortaucipir f-18","LY-3191748","LY3191748","T-807 F-18","T807 F-18","[F-18]T807"],"crossReferences":{"DailyMed":["flortaucipir%20f-18"],"drugbank":["DB14914"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2020 and has 3 approved indications."}
{"id":"CHEMBL3545257","canonicalSmiles":"CCC1=C[C@@H]2[C@H](C1)C[C@]2(CN)CC(=O)O.O=S(=O)(O)c1ccccc1","inchiKey":"OKJXJRVWXYRSAN-TXULWXBWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MIROGABALIN BESYLATE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL3545125","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["DS-5565","Ds-5565","Mirogabalin","Mirogabalin besilate","Mirogabalin besylate"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3707279","drugType":"Unknown","blackBoxWarning":false,"name":"ADAGLOXAD SIMOLENIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Adagloxad simolenin","OBI-822","OPT-822"],"description":"Unknown drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL3707312","canonicalSmiles":"COC(=O)c1cccc(CCN(C)CCC[C@@](C#N)(c2ccc(OC)c(OC)c2)C(C)C)c1","inchiKey":"VAZNEHLGJGSQEL-MHZLTWQESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ETRIPAMIL","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["(-)-MSP-2017","Etripamil","MS)-MSP-2017","MSP-2017"],"crossReferences":{"drugbank":["DB12605"]},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL3707316","drugType":"Small molecule","blackBoxWarning":false,"name":"ND0801","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Nd0801"],"linkedTargets":{"rows":["ENSG00000175344"],"count":1},"linkedDiseases":{"rows":["EFO_0003888"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3740500","canonicalSmiles":"CC(C)[C@]12O[C@H]1[C@@H]1O[C@@]13[C@@]1(C)CCC4=C(COC4=O)[C@@H]1C[C@@H]1O[C@@]13[C@@H]2OCOP(=O)([O-])[O-].[Na+].[Na+]","inchiKey":"ZHBJMVNZRZUQEP-KIKMAQITSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"MINNELIDE","maximumClinicalTrialPhase":2,"parentId":"CHEMBL3742465","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Minnelide"],"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL390674","canonicalSmiles":"Cc1cc(Oc2ccc3c(c2)OCO3)nc(Oc2ccc(-n3ccnc3)cc2)n1","inchiKey":"QQBNDYARFVOEGW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL390674","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07029"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL405355","canonicalSmiles":"COC(=O)C1=C(C)NC(C)=C(C(=O)OCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)[C@H]1c1cccc([N+](=O)[O-])c1","inchiKey":"SVJMLYUFVDMUHP-XIFFEERXSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NIGULDIPINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["(+)-niguldipine","Niguldipine"],"crossReferences":{"PubChem":["11113931","11113932"],"drugbank":["DB09239"]},"childChemblIds":["CHEMBL2303676"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4065122","canonicalSmiles":"C[C@H]1CN(C2COC2)CCN1c1ccc(Nc2cc(-c3ccnc(N4CCn5c(cc6c5CC(C)(C)C6)C4=O)c3CO)cn(C)c2=O)nc1","inchiKey":"WNEODWDFDXWOLU-QHCPKHFHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FENEBRUTINIB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Fenebrutinib","G-02599853","G02599853","GDC-0853","Gdc-0853","RG-7845","RG7845","RO-7010939","RO7010939"],"crossReferences":{"drugbank":["DB14785"]},"linkedTargets":{"rows":["ENSG00000010671"],"count":1},"linkedDiseases":{"rows":["EFO_0000685","EFO_0005531","EFO_0003840","MONDO_0005301","EFO_0002690"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL415087","canonicalSmiles":"Clc1ccc(C(OCCN2CCCCC2)c2ccccc2)cc1","inchiKey":"FLNXBVJLPJNOSI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CLOPERASTINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cloperastine","Cloperastine fendizoate","Cloperastine hydrochloride","HT-11","NSC-758635"],"crossReferences":{"Wikipedia":["Cloperastine"],"drugbank":["DB09002"]},"childChemblIds":["CHEMBL1492516"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL427409","canonicalSmiles":"NC[C@H]1O[C@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O)[C@H]2O)[C@H](N)[C@@H](O)[C@@H]1O","inchiKey":"SYJXFKPQNSDJLI-HKEUSBCWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NEAMINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Neamine"],"crossReferences":{"drugbank":["DB04808"],"chEBI":["7489"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL429736","canonicalSmiles":"CC[C@H](C)[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)N1CCOCC1)c1coc(C)n1","inchiKey":"PLVGDGRBPMVYPB-FDUHJNRSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RETOSIBAN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GSK-221149","GSK-221149A","GSK221149","GSK221149A","Retosiban"],"crossReferences":{"drugbank":["DB11818"]},"linkedTargets":{"rows":["ENSG00000180914"],"count":1},"linkedDiseases":{"rows":["EFO_0003917"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL4297628","canonicalSmiles":"NCCCC[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(N)=O)C(c1ccccc1)c1ccccc1","inchiKey":"GGAKLYWEFZCVIT-TVEKFXMRSA-N","drugType":"Protein","blackBoxWarning":false,"name":"RUXOTEMITIDE","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Kkwwkkw-.beta.-phenyl-fk-nh2","Kkwwkkwdipk-nh2","Ltx 315","Ltx-315","Oncopore","Ruxotemitide"],"crossReferences":{"drugbank":["DB12748"]},"description":"Protein drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4297967","drugType":"Unknown","blackBoxWarning":false,"name":"GSK-3050002","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GSK-3050002","GSK3050002","Gsk-3050002","Gsk3050002","HGS-1035","HGS1035","KANAB071"],"description":"Unknown drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4298091","drugType":"Antibody","blackBoxWarning":false,"name":"CIBISATAMAB","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cea cd3 tcb","Cibisatamab","RG-7802","RG7802","RO 6958688","RO-6958688","RO6958688","Ro 6958688","Ro6958688"],"description":"Antibody drug with a maximum clinical trial phase of I (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4298096","drugType":"Unknown","blackBoxWarning":false,"name":"MIK-665","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Mik-665","S 64315","S-64315","S64315"],"description":"Unknown drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4298097","drugType":"Antibody","blackBoxWarning":false,"name":"ROMILKIMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Hutbti3_2_1","Romilkimab","SAR-156597","SAR156597","Sar156597"],"linkedTargets":{"rows":["ENSG00000113520","ENSG00000169194"],"count":2},"linkedDiseases":{"rows":["EFO_0000768","EFO_0000717"],"count":2},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL438605","canonicalSmiles":"C[C@@]1(O)[C@H](O)[C@@H](CO)O[C@H]1n1ccc(N)nc1=O","inchiKey":"PPUDLEUZKVJXSZ-VPCXQMTMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"2'-C-Mecytosine","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["2'-C-Mecytosine","2'-C-Methylcytidine","2'C-Me-C"],"crossReferences":{"drugbank":["DB13921"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4594322","drugType":"Protein","blackBoxWarning":false,"name":"EFTOZANERMIN ALFA","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ABBV-621","Abbv 621","Abbv-621","Eftozanermin alfa"],"description":"Protein drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4594376","canonicalSmiles":"CCc1[nH]nc(C(=O)Nc2ccc([C@H]3CNCCO3)cc2)c1C","inchiKey":"XHHXGKRFUPEPFM-OAHLLOKOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RALMITARONT","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["RG-7906","RG7906","RO-6889450","RO6889450","Ralmitaront","Ro6889450"],"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4594426","canonicalSmiles":"N#Cc1ccc(COc2ccc(C#Cc3ccc(C(F)(F)[C@](O)(Cn4cnnn4)c4ccc(F)cc4F)nc3)cc2)cc1","inchiKey":"UDGASIIGNCBLSI-PMERELPUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VT-1598","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["VT-1598","Vt-1598"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4650406","drugType":"Antibody","blackBoxWarning":false,"name":"LEVILIMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BCD-089","Bcd-089","Levilimab"],"linkedTargets":{"rows":["ENSG00000160712"],"count":1},"linkedDiseases":{"rows":["EFO_0000685","MONDO_0100096"],"count":2},"description":"Antibody drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4650481","drugType":"Unknown","blackBoxWarning":false,"name":"JMT-101","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["JMT-101","JMT101","Jmt-101","Jmt101"],"description":"Unknown drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL468900","canonicalSmiles":"O=C(NCc1cccnc1)c1cc(C(=O)NCc2cccnc2)ncn1","inchiKey":"NHPBWKYFMTXWAA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL468900","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04761"],"chEBI":["593538"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL472","canonicalSmiles":"COc1ccc(Cl)cc1C(=O)NCCc1ccc(S(=O)(=O)NC(=O)NC2CCCCC2)cc1","inchiKey":"ZNNLBTZKUZBEKO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GLYBURIDE","yearOfFirstApproval":1984,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Calabren","Daonil","Diabeta","Diabetamide 2.5","Diabetamide 5","Euglucon","Gliken","Glyburide","Glyburide (micronized)","Glynase","Glynase Prestab","Lederglib","Libanil","Malix","Micronase","Semi-daonil"],"synonyms":["Cirara","Glibenclamide","Glibenclamidum","Glybenclamide","Glyburide","HB 419","HB-419","NSC-759618","U-26,45","U-26,452","U-26452"],"crossReferences":{"DailyMed":["glyburide"],"PubChem":["11111219","11112597","11113353","144203709","144211075","170464964","26747031","26747032","26751550","50100249","50104148","50104149","50104150","50126365","56422139","85231061","855894"],"TG-GATEs":["42"],"Wikipedia":["Glibenclamide"],"drugbank":["DB01016"],"chEBI":["5441"]},"linkedTargets":{"rows":["ENSG00000187486","ENSG00000006071"],"count":2},"linkedDiseases":{"rows":["EFO_0004593","HP_0002140","EFO_0000713","EFO_0000712","MONDO_0005147","EFO_1001919","MONDO_0043510","MONDO_0005148","EFO_0000400","EFO_0003913"],"count":10},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1984 and is indicated for type 2 diabetes mellitus and diabetes mellitus and has 7 investigational indications."}
{"id":"CHEMBL4802160","canonicalSmiles":"COC[C@H]1CN(C(=O)[C@]2(F)CN(C3CCCC3)C[C@H]2c2ccc(OC)cc2)C[C@@H]1c1ccc(C(F)(F)F)cc1N1CCC(C(=O)O)CC1","inchiKey":"MUNWOYRHJPWQNE-GMFUQMJFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DERSIMELAGON","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Dersimelagon","MT-7117","Mt-7117"],"childChemblIds":["CHEMBL4802244"],"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4802170","drugType":"Unknown","blackBoxWarning":false,"name":"CC-90005","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CC-90005","Cc-90005"],"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL491473","canonicalSmiles":"COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1","inchiKey":"XXJWYDDUDKYVKI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CEDIRANIB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Recentin"],"synonyms":["AZD-2171","AZD2171","Azd-2171","Cediranib","ZD-2171"],"crossReferences":{"PubChem":["103905340","137275941"],"drugbank":["DB04849"]},"childChemblIds":["CHEMBL2103798"],"linkedTargets":{"rows":["ENSG00000134853","ENSG00000128052","ENSG00000102755","ENSG00000037280","ENSG00000113721","ENSG00000157404"],"count":6},"linkedDiseases":{"rows":["EFO_1000403","EFO_0003891","EFO_0000681","EFO_1001465","MONDO_0007254","EFO_1000657","MONDO_0002087","EFO_0000305","EFO_1001951","EFO_0000565","MONDO_0001056","EFO_1001480","MONDO_0002158","EFO_0000588","MONDO_0002974","EFO_0009709","EFO_0000389","MONDO_0008903","EFO_0000770","EFO_0000182","EFO_0000673","EFO_0002617","EFO_0000616","EFO_0003893","MONDO_0008170","EFO_0000349","EFO_0000222","MONDO_0023619","EFO_0003060","MONDO_0003865","MONDO_0008315","EFO_0000311","EFO_0007143","EFO_0006861","EFO_0000095","EFO_0002892","MONDO_0011962","EFO_0000702","EFO_0003833","EFO_0000519"],"count":40},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 39 investigational indications."}
{"id":"CHEMBL498","canonicalSmiles":"CCCNC(=O)NS(=O)(=O)c1ccc(Cl)cc1","inchiKey":"RKWGIWYCVPQPMF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHLORPROPAMIDE","yearOfFirstApproval":1958,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Chlorpropamide","Diabemide","Diabinese","Glucamide","Glymese","Melitase"],"synonyms":["Chlorpropamide","NSC-44634","NSC-626720"],"crossReferences":{"PubChem":["11110918","11110919","144203653","144208589","144213106","170464898","17389965","50103916","56423142","855559"],"TG-GATEs":["80"],"Wikipedia":["Chlorpropamide"],"drugbank":["DB00672"],"chEBI":["3650"]},"linkedTargets":{"rows":["ENSG00000187486","ENSG00000006071"],"count":2},"linkedDiseases":{"rows":["MONDO_0005148","EFO_0000400"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1958 and is indicated for diabetes mellitus and type 2 diabetes mellitus."}
{"id":"CHEMBL501637","canonicalSmiles":"CC(C)=CCC[C@](C)(O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)[C@H]1CC[C@]2(C)[C@@H]1[C@H](O)C[C@@H]1[C@@]3(C)CC[C@H](O)C(C)(C)[C@@H]3[C@@H](O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)C[C@]12C","inchiKey":"YURJSTAIMNSZAE-HHNZYBFYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GINSENOSIDE RG1","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ginsenoside Rg1"],"crossReferences":{"Wikipedia":["Ginsenoside"],"drugbank":["DB06750"],"chEBI":["67987"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL539697","canonicalSmiles":"CCCCCCOC(=O)/N=C(\\N)c1ccc(NCc2nc3cc(C(=O)N(CCC(=O)OCC)c4ccccn4)ccc3n2C)cc1","inchiKey":"KSGXQBZTULBEEQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"DABIGATRAN ETEXILATE","yearOfFirstApproval":2010,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Pradaxa"],"synonyms":["BIBR 1048","BIBR 1048 BS RS1","BIBR-1048","BIBR-1048-BS-RS1","Dabigatran etexilate","Dabigatran etexilate methanesulfonate"],"crossReferences":{"DailyMed":["dabigatran%20etexilate%20mesylate"],"PubChem":["170466107"],"Wikipedia":["Dabigatran"],"drugbank":["DB06695"],"chEBI":["70746"]},"childChemblIds":["CHEMBL1615369"],"linkedTargets":{"rows":["ENSG00000180210"],"count":1},"linkedDiseases":{"rows":["EFO_0000275","EFO_0003095","HP_0000726","EFO_0001645","EFO_0004286","HP_0001907","HP_0000083","HP_0001871","MONDO_0000831","EFO_0003827","EFO_0000712","EFO_0003884","EFO_0000673","EFO_1000652","EFO_0003907","HP_0004419","HP_0004936"],"count":17},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2010 and has 5 approved and 12 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL563168","canonicalSmiles":"CCNC(=O)c1cc2c(-c3ccc(Cl)cc3Cl)nc(N)nc2s1","inchiKey":"YPEOXUOUTBMBCX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL563168","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08789"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL568737","canonicalSmiles":"CC(C)CC(=O)O","inchiKey":"GWYFCOCPABKNJV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"3-METHYLBUTANOIC ACID","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["3-Methylbutanoate","Isovaleric Acid"],"crossReferences":{"PubChem":["144208802"],"Wikipedia":["3-Methylbutanoic_acid"],"drugbank":["DB03750"],"chEBI":["28484"]},"childChemblIds":["CHEMBL1762642"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL571700","canonicalSmiles":"CN(C)C(=S)SC(=S)N(C)C","inchiKey":"REQPQFUJGGOFQL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BIS(DIMETHYLAMINETHIOCARBONYL)MONOSULFIDE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144205209","144208752","144213197","170465567","26754501","29215363"],"drugbank":["DB14178"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL593125","canonicalSmiles":"O=c1ccn([C@@H]2O[C@H](COP(=O)(O)OP(=O)(O)O[C@H]3O[C@H](CO)[C@@H](F)[C@H](O)[C@H]3O)[C@@H](O)[C@H]2O)c(=O)[nH]1","inchiKey":"OAPPZHVTNHJVAL-JZMIEXBBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL593125","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04097"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL76725","canonicalSmiles":"N=C(N)NCC1COc2ccccc2O1","inchiKey":"HIUVKVDQFXDZHU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GUANOXAN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Guanoxan"],"crossReferences":{"PubChem":["144205384","29216144"],"drugbank":["DB13211"]},"childChemblIds":["CHEMBL1742462"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL85231","canonicalSmiles":"CN(C)CC(Oc1ccccc1)Oc1ccccc1","inchiKey":"QNMGHBMGNRQPNL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MEDIFOXAMINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Medifoxamine"],"crossReferences":{"drugbank":["DB13219"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL8946","canonicalSmiles":"CCc1cc(Cl)c(OC)c(C(=O)NC[C@@H]2CCCN2CC)c1O","inchiKey":"AADCDMQTJNYOSS-LBPRGKRZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ETICLOPRIDE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Eticlopride"],"crossReferences":{"PubChem":["11112879","26755017"],"Wikipedia":["Eticlopride"],"drugbank":["DB15492"]},"childChemblIds":["CHEMBL1256917"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL93","canonicalSmiles":"CC(c1cc2ccccc2s1)N(O)C(N)=O","inchiKey":"MWLSOWXNZPKENC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ZILEUTON","yearOfFirstApproval":1996,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Zyflo","Zyflo cr"],"synonyms":["A-64077","ABBOTT-64077","NSC-730712","NSC-759277","Zileuton"],"crossReferences":{"DailyMed":["zileuton"],"PubChem":["144205233","144211465","170465222","174007276","26719885","29215400"],"Wikipedia":["Zileuton"],"drugbank":["DB00744"],"chEBI":["10112"]},"linkedTargets":{"rows":["ENSG00000012779"],"count":1},"linkedDiseases":{"rows":["MP_0001845","EFO_0000339","Orphanet_232","MONDO_0008903","EFO_0000768","MONDO_0004979","EFO_0003768","EFO_0000341","EFO_0003894"],"count":9},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1996 and is indicated for asthma and has 8 investigational indications."}
